Alan Barge
Directeur/Membre du Conseil chez THERACRYF PLC
Profil
Dr. Alan Barge, MD, is a Venture Partner at Delin Ventures Ltd., a Senior Independent Non-executive Director at TheraCryf Plc and a Director & Investor Director at Oribiotech Ltd.
He is on the Board of Directors at TheraCryf Plc, West Thorpe (2011) Ltd.
and Oribiotech Ltd.
Dr. Barge was previously employed as a Chairman-Supervisory Board by Modra Pharmaceuticals BV, a Chief Medical Officer by BerGenBio ASA, a Senior Vice President-Oncology by ASLAN Pharmaceuticals Pte Ltd., a Vice President-Clinical & Head-Oncology by AstraZeneca PLC, and a Global Medical Director-European by Amgen, Inc. He received his graduate degree from the University of Oxford.
Postes actifs de Alan Barge
| Sociétés | Poste | Début |
|---|---|---|
| THERACRYF PLC | Directeur/Membre du Conseil | 21/10/2015 |
| West Thorpe (2011) Ltd. | Directeur/Membre du Conseil | - |
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Directeur en chef des Investissements | - |
Delin Ventures Ltd.
 Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Private Equity Investor | 01/03/2019 |
Anciens postes connus de Alan Barge
| Sociétés | Poste | Fin |
|---|---|---|
| BERGENBIO ASA | Directeur Technique/Scientifique/R&D | 13/03/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/12/2010 |
| AMGEN INC. | Corporate Officer/Principal | 01/09/1998 |
Modra Pharmaceuticals BV
 Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Président | - |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Fondateur | - |
Formation de Alan Barge
| University of Oxford | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AMGEN INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| THERACRYF PLC | Health Services |
| BERGENBIO ASA | Health Technology |
| Entreprise privées | 5 |
|---|---|
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
| West Thorpe (2011) Ltd. | |
Modra Pharmaceuticals BV
Modra Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology Modra Pharmaceuticals BV designs and develops oral formulations of commonly used anti-cancer drugs. It is a clinical-stage company which develops series of oral formulations of existing IV anticancer drugs which reduce the side effects common to IV formulations, thereby improving patient convenience. The company was founded in June 2010 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
Delin Ventures Ltd.
Delin Ventures Ltd. Investment ManagersFinance Delin Ventures Ltd. (Delin Ventures) is a venture capital firm founded in 2013 by Igor Linshits. The firm headquartered in London, United Kingdom. | Finance |
Oribiotech Ltd.
Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom. | Health Technology |
